中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
6期
17-20
,共4页
子宫内膜癌%连接黏附分子1%肌层浸润
子宮內膜癌%連接黏附分子1%肌層浸潤
자궁내막암%련접점부분자1%기층침윤
Endometrial carcinoma%Junctional adhesion molecule 1%Myometrial invasion
目的:探讨JAM-1在不同肌层浸润深度的子宫内膜癌组织中的表达及意义。方法73例子宫内膜癌患者,其中癌细胞无肌层浸润18例,浅层浸润38例,深层浸润17例,采用免疫组化法检测JAM-1在无、浅、深三组浸润深度的表达情况。结果 JAM-1表达在子宫内膜癌癌细胞、腺细胞的胞膜及胞浆,随肌层浸润程度的增加JAM-1的表达显著减弱,差异有统计学意义(P<0.05)。结论子宫内膜癌JAM-1的表达与癌细胞的浸润程度呈反比,提示JAM-1可能与子宫内膜癌的浸润、侵袭相关。
目的:探討JAM-1在不同肌層浸潤深度的子宮內膜癌組織中的錶達及意義。方法73例子宮內膜癌患者,其中癌細胞無肌層浸潤18例,淺層浸潤38例,深層浸潤17例,採用免疫組化法檢測JAM-1在無、淺、深三組浸潤深度的錶達情況。結果 JAM-1錶達在子宮內膜癌癌細胞、腺細胞的胞膜及胞漿,隨肌層浸潤程度的增加JAM-1的錶達顯著減弱,差異有統計學意義(P<0.05)。結論子宮內膜癌JAM-1的錶達與癌細胞的浸潤程度呈反比,提示JAM-1可能與子宮內膜癌的浸潤、侵襲相關。
목적:탐토JAM-1재불동기층침윤심도적자궁내막암조직중적표체급의의。방법73례자궁내막암환자,기중암세포무기층침윤18례,천층침윤38례,심층침윤17례,채용면역조화법검측JAM-1재무、천、심삼조침윤심도적표체정황。결과 JAM-1표체재자궁내막암암세포、선세포적포막급포장,수기층침윤정도적증가JAM-1적표체현저감약,차이유통계학의의(P<0.05)。결론자궁내막암JAM-1적표체여암세포적침윤정도정반비,제시JAM-1가능여자궁내막암적침윤、침습상관。
Objective To investigate the expression and significance of JAM-1 in the endometrial carcinoma tissues with different myometrial invasion depth. Methods Seventy-three patients with endometrial carcinoma were selected, of which 18 patients were without myometrial invasion, 28 patients had superficial invasion and 17 patients had deep invasion. The immunohistochemistry was used to detect the expression situation of JAM-1 in the three groups with no superficial and deep invasion. Results JAM-1 expressed in the cancer cells of endometrial carcinoma and cell membrane and cytoplasm of glandular cells. As the depth of myometrial invasion increased, the expression of JAM-1 weakened significantly, with statistically significant differences(P < 0.05). Conclusion In endometrial carcinoma, the expression of JAM-1 and invasion depth of cancer cells are negatively correlated, suggesting that JAM-1 may be associated with the invasion of endometrial carcinoma.